CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $64.61 ($1,615,160)
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $66.84 ($1,671,084)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $75.91 ($1,897,747)
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $61.59 ($1,539,862)
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Other events
- UPLOAD Other SEC-generated Letter
- 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
Page 16 of 45 · 883 filings